Axonics Modulation Technologies, Inc.
(NASDAQ : AXNX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DXCMDexCom, Inc. 5.70%364.498.2%$1010.73m
ABTAbbott Laboratories 1.85%89.880.8%$687.47m
MDTMedtronic Plc 5.18%102.010.6%$656.19m
BDXBecton, Dickinson & Co. -0.68%241.891.0%$647.52m
DHRDanaher Corp. 2.61%173.190.7%$645.19m
TMOThermo Fisher Scientific, Inc. 1.72%354.131.0%$503.14m
BSXBoston Scientific Corp. 3.77%38.831.0%$437.50m
ISRGIntuitive Surgical, Inc. 5.05%592.762.4%$398.72m
SYKStryker Corp. 4.48%206.951.3%$354.31m
INOInovio Pharmaceuticals, Inc. 0.42%11.936.3%$337.96m
ALGNAlign Technology, Inc. 10.82%288.216.4%$324.61m
WSTWest Pharmaceutical Services, Inc. 0.16%205.721.6%$293.42m
BAXBaxter International, Inc. 0.60%89.161.8%$247.08m
ZBHZimmer Biomet Holdings, Inc. 6.12%137.441.7%$203.62m
QDELQuidel Corp. -2.07%153.647.7%$202.30m

Company Profile

Axonics Modulation Technologies, Inc. operates as a medical technology company, which engages in the design, development, and commercialization of sacral neuromodulation solutions. The firm focuses on the treatment of patients with overactive bladder (OAB), fecal incontinence (FI), and urinary retention (UR). It offers rechargeable SNM system, which delivers mild electrical pulses to the targeted sacral nerve in order to restore normal communication to and from the brain to reduce the symptoms of OAB, FI, and UR. The company was founded by Guang Qiang Jiang, Danny L. Dearen, Timothy Deer, and Michael V. Williamson in March 2012 and is headquartered in Irvine, CA.